One of the highlights from the OBIO Investment Summit was the opportunity to connect with people doing meaningful work across the life sciences. NGBi podcast host Jim Wilson spoke with… Read More
Formulation and aseptic fill–finish successfully completed for Aramis Biotechnologies’ phase 1/2 clinical studies. MONTRÉAL and QUÉBEC CITY – Aramis Biotechnologies Inc., a Canadian company pioneering and a global leader in plant‑based… Read More
BURLINGTON, N.C. – Labcorp, a global leader of innovative and comprehensive laboratory services, announced the signing of a new multi‑year partnership agreement with SOMOS, one of New York’s largest Independent Practice… Read More
VANCOUVER, BC, – WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world’s most reputable and high-impact surgical journals…. Read More
The draft recommendation for Kisqali® (ribociclib tablets) from Canada’s Drug Agency (CDA-AMC) supports public reimbursement for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II-III early breast cancer… Read More
